PharmaLectures.com

Courses › Pharma training by country › Indian companies that cracked Europe, and what they did differently

Indian companies that cracked Europe, and what they did differently

Take a European entry plan to your partner that survives their first hard question.

  • 5 audio modulesthree lengths each
  • 50 min to 4 h 10 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • India companieswho it is written for

Why this training matters

Your team presents the entry plan to a German partner. Someone asks how the product will be priced and reimbursed country by country, and nobody has an answer. The partner goes quiet, the talks stall for months, and your board asks why the pipeline is empty.

What changes after this course

Your team talks to European Medicines Agency reviewers and partners in their terms, picks the entry model before the first meeting, and fixes packaging and distribution before an inspector sees them. You hold a certificate for each learner and a training record for each person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs lead stops treating the European Medicines Agency as a bigger version of the Central Drugs Standard Control Organisation. The Marketing Authorisation Application goes in under the Common Technical Document structure, with the route chosen first and the Marketing Authorisation Holder's duties written down, so the national competent authority has less to query and the timeline holds.

The entry decision stops waiting on a long meeting. Your business development head compares the centralised, decentralised and national routes and the joint venture option against country pricing and reimbursement rules, then picks a model that still pays after the partner's cut. Your quality lead walks into a European Union Good Manufacturing Practice inspection with the file already answering the questions.

Packaging, leaflets and safety reporting get settled before printing and shipping. Your pharmacovigilance officer sets up reporting to EudraVigilance under Good Pharmacovigilance Practices Module VI, your distribution manager holds temperature records that stand up under Good Distribution Practice, and your risk management plan is updated before the national competent authority asks.

When a safety report or a quality defect lands on a Friday, your team follows a written order of steps under Directive 2001/83/EC instead of phoning around. The Federal Institute for Drugs and Medical Devices hears from you early, in plain terms, and you hold a training record per person to show your next auditor.

Who needs this training

  • Regulatory Affairs Manager

    The day a national competent authority queries your file, you know which route you filed under, which Common Technical Document module the answer sits in, and what the Marketing Authorisation Holder must supply.

  • Head of International Business Development

    In the partner meeting, you answer the pricing and reimbursement question for that country and put a joint venture, a licence deal or a distributor on the table with the margin worked out.

  • Quality Assurance Director

    Before the inspector arrives, you check the Quality Management System against European Union Good Manufacturing Practice and know which answers the importer's Qualified Person will need to sign a batch for the European market.

  • Pharmacovigilance Manager

    When an adverse reaction report arrives from a European patient, you know who submits it to EudraVigilance, in what form, and how soon, with Module VI as your reference.

  • Supply Chain Manager

    When a consignment is questioned on arrival, you show the temperature records and the distributor agreement that Good Distribution Practice expects, instead of phoning round to find them.

Roles: Owner, CEO and board, Business development and export sales

Businesses: every kind of pharma company

Countries: India

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Choose between the centralised and decentralised procedure for a given product and write down the reason.
  2. List which duties sit with the Marketing Authorisation Holder and which stay with your own company.
  3. Compare a joint venture, a licence and a distributor for one European country against its pricing and reimbursement rules.
  4. Check a pack and package leaflet against the labelling rules in Directive 2001/83/EC before printing.
  5. Route an adverse reaction report to EudraVigilance following Good Pharmacovigilance Practices Module VI.
  6. Draw up a checklist for a cold chain and a distributor agreement that follows Good Distribution Practice.
  7. Prepare a risk management plan update and submit it to the competent authority when a significant change requires it.

What the company gets

  • Your Marketing Authorisation Application reaches the European Medicines Agency or a national competent authority with the route chosen and the Marketing Authorisation Holder's duties written down.
  • You walk into a partner negotiation with a margin worked out under each country's pricing and reimbursement rules, so fewer talks end in silence.
  • Your packaging, leaflets and safety reporting meet Directive 2001/83/EC and Good Pharmacovigilance Practices before the first shipment leaves.
  • Your inspection file for European Union Good Manufacturing Practice and Good Distribution Practice has a straight answer ready for each question an inspector is likely to ask.
  • You hold a certificate for each learner and a training record per person to show at your next corporate audit.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 5 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing50 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 05 min25 min a module, for regulatory, quality and business-development staff
Expanded4 h 10 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing50 min
Business development and export salesBriefing50 min

Course outline: 5 modules

5 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Drop the home-market habits that slow a European Medicines Agency application

    • Why a reply that satisfied the Central Drugs Standard Control Organisation can stop the clock in Europe.
    • What to have in the plant before a European Union Good Manufacturing Practice inspector books the visit.
    • The duties that move to your Marketing Authorisation Holder, and the ones that stay on your desk.
  2. 2Choose the entry model that keeps your margin once national prices apply

    • When the centralised procedure is your route and when the decentralised procedure fits better.
    • How a joint venture gives you a foothold in Germany, and what to weigh before you sign it.
    • The national pricing and reimbursement rules that cut your margin after the partner has signed.
  3. 3Fit packaging and pharmacovigilance to Directive 2001/83/EC

    • The label and package leaflet details in Directive 2001/83/EC that you must settle before printing.
    • Why Good Pharmacovigilance Practices Module VI sets the clock on every adverse reaction report you receive.
    • How to handle a quality defect found in one Member State while stock sits in several others.
  4. 4Build a cold chain and distribution network that crosses European borders

    • The records under Good Distribution Practice that protect you when a delivery arrives warm.
    • Which clauses make a European distributor answer for quality as well as sales.
    • How to earn a hearing with European key opinion leaders when nobody has heard of your company.
  5. 5Keep post-marketing surveillance and risk management plans inspection-ready

    • What to do the day a post-marketing safety report reaches your desk.
    • Why early contact with the Federal Institute for Drugs and Medical Devices keeps questions small.
    • The risk management plan updates to send before a national competent authority has to ask for them.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

5 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 50 min in the briefing length and 4 h 10 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for India companies. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 45 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team